WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.

WHO Expert Committee on Biological Standardization fifty-sixth report.
Wydane: (2007)

WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
Wydane: (2003)

Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
od: Willig, Sidney H., 1919-
Wydane: (2000)

WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.
Wydane: (2006)

WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
Wydane: (2005)

WHO Expert Committee on Biological Standardization : sixty-third report. /
Wydane: (2014)

The selection and use of essential medicines
Wydane: (2006)

WHO Expert Committee on Biological Standardization fifty-second report.
Wydane: (2004)

WHO Expert Committee on Biological Standardization fifty-fourth report.
Wydane: (2005)

WHO Expert Committee on Biological Standardization : sixty-first report.
Wydane: (2013)

Pharmaceutical drug analysis methodology - theory - instrumentation - pharmaceutical assays - cognote assays.
od: Kar, Ashutosh
Wydane: (2005)

Reviews in pharmaceutical and biomedical analysis
Wydane: (2010)

Biomedical chromatography
Wydane: (2010)

Organelle-specific pharmaceutical nanotechnology
Wydane: (2010)

Specification of drug substances and products : development and validation of analytical methods /
Wydane: (2014)

Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
od: Osmane, Malik
Wydane: (2014)

Pharmaceutical industry innovation and developments /
Wydane: (2011)

Dielectric analysis of pharmaceutical systems
od: Craig, Duncan Q. M.
Wydane: (1995)

Flow injection analysis of pharmaceuticals automation in the laboratory /
od: Martínez Calatayud, José
Wydane: (1996)

Characterization of impurities and degradants using mass spectrometry
Wydane: (2011)

HPLC methods for recently approved pharmaceuticals
od: Lunn, George
Wydane: (2005)

Leachables and extractables handbook safety evaluation, qualification, and best practices applied to inhalation drug products /
Wydane: (2012)

Continuous processing in pharmaceutical manufacturing /
Wydane: (2015)

Pharmaceutical blending and mixing /
Wydane: (2015)

Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Wydane: (2004)

The selection and use of essential medicines report of the WHO Expert Committee, 2002.
Wydane: (2003)

The war against counterfeit medicine my story /
od: Akunyili, Dora Nkem
Wydane: (2011)

The selection and use of essential medicines report of the WHO Expert Committee, 2003 ; (including the 13th Model List of Essential Medicines).
Wydane: (2004)

Pharmaceutical production facilities design and applications /
od: Cole, Graham, 1934-
Wydane: (1998)

Thirty-sixth report
Wydane: (2002)

Drug monitoring by HPLC recent developments /
od: Samanidou, Victoria
Wydane: (2010)

Effective drug regulation a multicountry study /
od: Ratanawijitrasin, Sauwakon
Wydane: (2002)

Manufacturing of pharmaceutical proteins : from technology to economy /
od: Behme, Stefan
Wydane: (2015)

The greening of pharmaceutical engineering. practice, analysis, and methodology /
od: Islam, Rafiqul, 1959-
Wydane: (2015)

Integrated pharmaceutics applied preformulation, product design, and regulatory science /
od: Al-Achi, Antoine, 1955-
Wydane: (2013)

ADME-enabling technologies for drug design and development
Wydane: (2012)